Skip to main content
Clinical Trials/PACTR202303867267716
PACTR202303867267716Not yet recruitingPhase 3

The effectiveness of a customised digital adherence tool on HIV treatment outcomes in adolescents and young adults living with HIV in Blantyre, Malawi

Kilimanjaro Clinical Research Institute0 sites240 target enrollmentStarted: March 22, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
240

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
13 Year(s) to 18 Year(s) (—)
Sex
All

Inclusion Criteria

  • Participants must be on first line ART regimen (Tenofovir/Lamuvidine/Dolutegravir) or (Tenofovir/Lamuvidine/Efavirenz)
  • Participants must have had full disclosure of their HIV status
  • Participants must be able to read and understand Chichewa or English
  • Participants must be competent in the use of mobile devices.

Exclusion Criteria

  • Hospitalisation at the time of study entry
  • Prior participation in digital adherence health research
  • Enrolment in other HIV-related studies
  • Treatment for a comorbidity that significantly increases the participants’ pill burden.

Investigators

Similar Trials